MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer

Breast Cancer Research

Volumn 15, Issue 4, 2013, Pages

  Guo, Qi J ^a   Mills, Jamie N ^a   Bandurraga, Savannah G ^a   Nogueira, Lourdes M ^a   Mason, Natalie J ^a   Camp, E Ramsay ^a   Larue, Amanda C ^a   Turner, David P ^a   Findlay, Victoria J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

breast cancer; MicroRNA; migration; miR 510; peroxiredoxin1; tumorigenesis

Indexed keywords

MICRORNA; MICRORNA 510; PEROXIREDOXIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MESSENGER RNA; MIRN510 MICRORNA, HUMAN; PEROXIREDOXIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TUMOR GROWTH; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CELL MOTION; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR STEM CELL ASSAY; TUMOR VOLUME;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OXIDATION-REDUCTION; PEROXIREDOXINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84882487238     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3464     Document Type: Article

References (25)

1. Castano Z, Tracy K, McAllister SS. The tumor macroenvironment and systemic regulation of breast cancer progression. Int J Dev Biol 2011, 55:889-897. 10.1387/ijdb.113366zc, 22161844.
2. Drabsch Y, ten Dijke P. TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia 2011, 16:97-108. 10.1007/s10911-011-9217-1, 3095797, 21494783.
3. Drasin DJ, Robin TP, Ford HL. Breast cancer epithelial-to-mesenchymal transition:examining the functional consequences of plasticity. Breast Cancer Res 2011, 13:226. 10.1186/bcr3037, 3326549, 22078097.
4. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011, 13:228. 10.1186/bcr2940, 3326546, 22114869.
5. Nelson KM, Weiss GJ. MicroRNAs and cancer:past, present, and potential future. Mol Cancer Ther 2008, 7:3655-3660. 10.1158/1535-7163.MCT-08-0586, 19074842.
6. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269. 10.1038/nrc1840, 16557279.
7. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
8. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152. 10.1038/nature06487, 2782491, 18185580.
9. He L, Hannon GJ. MicroRNAs:small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
10. Cummins JM, Velculescu VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25:6220-6227. 10.1038/sj.onc.1209914, 17028602.
11. Kent OA, Mendell JT. A small piece in the cancer puzzle:microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25:6188-6196. 10.1038/sj.onc.1209913, 17028598.
12. Bartel DP, Chen CZ. Micromanagers of gene expression:the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
13. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
14. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E, Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210. 10.1038/ncb1681, 18193036.
15. Findlay VJ, Turner DP, Moussa O, Watson DK. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res 2008, 68:8499-8506. 10.1158/0008-5472.CAN-08-0907, 2680499, 18922924.
16. Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, Manevich Y, Beeson C, Neumann CA. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 2009, 28:1505-1517. 10.1038/emboj.2009.101, 2688529, 19369943.
17. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors?. Curr Opin Pharmacol 2007, 7:375-380. 10.1016/j.coph.2007.04.007, 17616437.
18. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003, 424:561-565. 10.1038/nature01819, 12891360.
19. Neumann CA, Cao J, Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 2009, 8:4072-4078. 10.4161/cc.8.24.10242, 19923889.
20. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107-1112. 10.1093/jnci/82.13.1107, 2359136.
21. Andachi Y. A novel biochemical method to identify target genes of individual microRNAs:identification of a new Caenorhabditis elegans let-7 target. RNA 2008, 14:2440-2451. 10.1261/rna.1139508, 2578851, 18824511.
22. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 2008, 24:489-497. 10.1016/j.tig.2008.07.004, 18778868.
23. Kapeller J, Houghton LA, Monnikes H, Walstab J, Moller D, Bonisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, Atkinson W, Fell C, Buchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008, 17:2967-2977. 10.1093/hmg/ddn195, 18614545.
24. Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 2010, 260:70-74. 10.1016/j.cellimm.2009.10.012, 19954774.
25. Goncalves K, Sullivan K, Phelan S. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells. Cancer Invest 2012, 30:38-47. 10.3109/07357907.2011.629382, 22236188.